Revolution Medicines (RVMD) Change in Receivables (2019 - 2024)
Revolution Medicines (RVMD) recorded quarterly Change in Receivables of -$1.3 million in Q1 2024, down 232.7% quarter-over-quarter from $945000.0 in Q4 2023, and down 84.96% on a YoY basis from -$8.3 million in Q2 2023.
Revolution Medicines (RVMD) Change in Receivables (2019 - 2024) Analysis & Trends
Revolution Medicines' Change in Receivables history runs 6 years deep, the most recent figure standing at -$1.3 million for Q1 2024.
- In Q1 2024, Change in Receivables fell 84.96% year-over-year to -$1.3 million; the TTM figure through Dec 2024 stood at -$1.3 million (up 63.32% YoY), while the FY2024 annual figure was -$1.3 million, up 63.32% from the prior year.
- Change in Receivables was -$1.3 million for Q1 2024 at Revolution Medicines, down from $945000.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $2.0 million in Q3 2020 to a low of -$2.9 million in Q4 2020.
- Historically, Change in Receivables has averaged -$513941.2 across 5 years, with a median of -$678000.0 in 2023.
- Biggest YoY gain for Change in Receivables was 2975.0% in 2020; the steepest drop was 1264.32% in 2020.
- A 5-year view of Change in Receivables shows it stood at -$2.9 million in 2020, then surged by 48.97% to -$1.5 million in 2021, then surged by 82.0% to -$267000.0 in 2022, then jumped by 453.93% to $945000.0 in 2023, then plunged by 232.7% to -$1.3 million in 2024.
- The last three Change in Receivables figures came in at -$1.3 million (Q1 2024), $945000.0 (Q4 2023), and -$2.2 million (Q3 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -4.08 Mn |
| 10 | Revolution Medicines | 32.33 Bn | 32.33 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -1.25 Mn |
| Mar 31, 2024 | -1.25 Mn |
| Dec 31, 2023 | 945,000.00 |
| Dec 31, 2023 | 945,000.00 |
| Sep 30, 2023 | -2.20 Mn |
| Sep 30, 2023 | -2.20 Mn |
| Jun 30, 2023 | -1.49 Mn |
| Jun 30, 2023 | -1.49 Mn |
| Mar 31, 2023 | -678,000.00 |
| Mar 31, 2023 | -678,000.00 |
| Dec 31, 2022 | -267,000.00 |
| Dec 31, 2022 | -267,000.00 |
| Sep 30, 2022 | -684,000.00 |
| Sep 30, 2022 | -684,000.00 |
| Jun 30, 2022 | 241,000.00 |
| Jun 30, 2022 | 241,000.00 |
| Mar 31, 2022 | -546,000.00 |
| Mar 31, 2022 | -546,000.00 |
| Dec 31, 2021 | -1.48 Mn |
| Dec 31, 2021 | -1.48 Mn |